Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D0XQ1W
|
||||
Former ID |
DIB002191
|
||||
Drug Name |
SDZ-62-434
|
||||
Synonyms |
5-[4-(Piperidinomethyl)phenyl]-2,3-dihydroimidazo[2,1-a]isoquinoline dihydrochloride
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Solid tumours [ICD9: 140-199, 210-229; ICD10:C00-D48] | Discontinued in Phase 1 | [545067] | ||
Structure |
Download2D MOL |
||||
Formula |
C22H25Cl2N3
|
||||
Canonical SMILES |
C1CCN(CC1)C2=CC=C(C=C2)C3=CC4=CC=CC=C4C5=NCCN35.Cl.Cl
|
||||
InChI |
1S/C22H23N3.2ClH/c1-4-13-24(14-5-1)19-10-8-17(9-11-19)21-16-18-6-2-3-7-20(18)22-23-12-15-25(21)22;;/h2-3,6-11,16H,1,4-5,12-15H2;2*1H
|
||||
InChIKey |
BKOQATFPPHQOQH-UHFFFAOYSA-N
|
||||
CAS Number |
CAS 115621-95-9
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Platelet-activating factor receptor | Target Info | Antagonist | [531635], [534010] | |
NetPath Pathway | IL5 Signaling Pathway | ||||
Leptin Signaling Pathway | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.